Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune (Idiopathic) Thrombocytopenic Purpura”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07017725
What this trial is testing

A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia

Who this might be right for
Chronic Immune Thrombocytopenia
CASI pharmaceuticals, Inc. 75
Not applicableStudy completedNCT00861224
What this trial is testing

Effects of Long-term Dosing of AMG 531 on Bone Marrow Morphology

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Amgen 10
Not applicableLooking for participantsNCT04014413
What this trial is testing

Safety and Efficacy of Fecal Microbiota Transplantation

Who this might be right for
Crohn DiseaseUlcerative ColitisCeliac Disease+24 more
Chinese University of Hong Kong 450
Testing effectiveness (Phase 2)Looking for participantsNCT06352281
What this trial is testing

Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)

Who this might be right for
ITP - Immune Thrombocytopenia
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 10
Testing effectiveness (Phase 2)Study completedNCT00718692
What this trial is testing

Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenic Purpura
Symphogen A/S 61
Testing effectiveness (Phase 2)Looking for participantsNCT06992128
What this trial is testing

Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 129
Early research (Phase 1)Looking for participantsNCT06826430
What this trial is testing

Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia

Who this might be right for
Autoimmune Thrombocytopenia
Juventas Cell Therapy Ltd. 12
Testing effectiveness (Phase 2)Ended earlyNCT05785819
What this trial is testing

VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia

Who this might be right for
Thrombocytopenia, ImmuneHeparin Induced Thrombocytopenia
Veralox Therapeutics 24
Early research (Phase 1)Ended earlyNCT02009761
What this trial is testing

Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Boehringer Ingelheim 6
Large-scale testing (Phase 3)Study completedNCT00540423
What this trial is testing

Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Chronic Idiopathic Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Idiopathic
GlaxoSmithKline 23
Post-approval studies (Phase 4)Not Yet RecruitingNCT07189910
What this trial is testing

Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 150
Large-scale testing (Phase 3)Study completedNCT00351468
What this trial is testing

EXTEND (Eltrombopag Extended Dosing Study)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
Novartis Pharmaceuticals 302
Large-scale testing (Phase 3)Study completedNCT01525836
What this trial is testing

RhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP

Who this might be right for
PurpuraIdiopathic Thrombocytopenic Purpura
Shandong University 123
Testing effectiveness (Phase 2)Study completedNCT03830749
What this trial is testing

Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenia
Humanity & Health Medical Group Limited 53
Not applicableStudy completedNCT01713855
What this trial is testing

Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura

Who this might be right for
Idiopathic Thrombocytopenic PurpuraImmune Thrombocytopenic Purpura
Neufeld, Ellis J, MD, PhD 10
Large-scale testing (Phase 3)Ended earlyNCT01433978
What this trial is testing

A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Eisai Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT05070845
What this trial is testing

Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Pfizer 91
Large-scale testing (Phase 3)WithdrawnNCT05046327
What this trial is testing

Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc.
Early research (Phase 1)Not Yet RecruitingNCT07574073
What this trial is testing

CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related Cytopenia

Who this might be right for
Anti-CD20 Monoclonal AntibodyBTK InhibitorsImmune Thrombocytopenia (ITP)+1 more
Qi deng 30
Early research (Phase 1)Not Yet RecruitingNCT07622329
What this trial is testing

A Clinical Study to Evaluate JCXH-213 in the Treatment of Adults With Primary Immune Thrombocytopenia

Who this might be right for
Thrombocytopenic Purpura, Immune
The General Hospital of Western Theater Command 4
Next Page